Terms: = Lung cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Prognosis
18 results:
1. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
[TBL] [Abstract] [Full Text] [Related]
2. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
[TBL] [Abstract] [Full Text] [Related]
3. UPF1 regulates foxo1 protein expression by promoting PBK transcription in non-small cell lung cancer.
Wang P; Li T; Fang L; Chen D; Qi H; Gu C
Biochem Biophys Res Commun; 2023 Jul; 666():10-20. PubMed ID: 37167719
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features and prognosis of primary pulmonary rhabdomyosarcoma in middle-aged and elderly patients: a case report and literature review.
Xiaoxia J; Guihua Z; Jiatai W; Xinghua Z; Xudong C; Yingze W
J Int Med Res; 2023 Mar; 51(3):3000605231159782. PubMed ID: 36883437
[TBL] [Abstract] [Full Text] [Related]
5. FOXF1 is required for the oncogenic properties of PAX3-foxo1 in rhabdomyosarcoma.
Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV
Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785
[TBL] [Abstract] [Full Text] [Related]
6. Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer.
Wang X; Jiang X; Li J; Wang J; Binang H; Shi S; Duan W; Zhao Y; Zhang Y
Thorac Cancer; 2020 Dec; 11(12):3436-3447. PubMed ID: 33107700
[TBL] [Abstract] [Full Text] [Related]
7. Vitamin D Represses the Aggressive Potential of Osteosarcoma.
Tahbazlahafi B; Paknejad M; Khaghani S; Sadegh-Nejadi S; Khalili E
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1312-1318. PubMed ID: 32955002
[TBL] [Abstract] [Full Text] [Related]
8. Prospects for miR-21 as a Target in the Treatment of lung Diseases.
Ding Y; Hou Y; Liu Y; Xie X; Cui Y; Nie H
Curr Pharm Des; 2021; 27(3):415-422. PubMed ID: 32867648
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting foxo1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract] [Full Text] [Related]
10. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated foxo1 degradation.
Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022
[TBL] [Abstract] [Full Text] [Related]
11. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent foxo1 and YAP signaling.
Liu H; Liu N; Zhao Y; Zhu X; Wang C; Liu Q; Gao C; Zhao X; Li J
Aging (Albany NY); 2019 Nov; 11(21):9643-9660. PubMed ID: 31689236
[TBL] [Abstract] [Full Text] [Related]
12. Regulation of programmed cell death ligand 1 expression by atypical protein kinase C lambda/iota in cutaneous angiosarcoma.
Kawamura A; Kawamura T; Riddell M; Hikita T; Yanagi T; Umemura H; Nakayama M
Cancer Sci; 2019 May; 110(5):1780-1789. PubMed ID: 30801864
[TBL] [Abstract] [Full Text] [Related]
13. WT1-interacting protein inhibits cell proliferation and tumorigenicity in non-small-cell lung cancer via the AKT/foxo1 axis.
Wu Z; Qiu M; Mi Z; Meng M; Guo Y; Jiang X; Fang J; Wang H; Zhao J; Liu Z; Qian D; Yuan Z
Mol Oncol; 2019 May; 13(5):1059-1074. PubMed ID: 30690883
[TBL] [Abstract] [Full Text] [Related]
14. aPKC controls endothelial growth by modulating c-Myc via foxo1 DNA-binding ability.
Riddell M; Nakayama A; Hikita T; Mirzapourshafiyi F; Kawamura T; Pasha A; Li M; Masuzawa M; Looso M; Steinbacher T; Ebnet K; Potente M; Hirose T; Ohno S; Fleming I; Gattenlöhner S; Aung PP; Phung T; Yamasaki O; Yanagi T; Umemura H; Nakayama M
Nat Commun; 2018 Dec; 9(1):5357. PubMed ID: 30559384
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.
Akın Kabalak P; Çiledağ A; Demir N; Çelik G; Yüksel C; Köycü G; Gökmen Öztuna D; Taner A; Kaya A; Kutlay H; Numanoğlu N; Savaş İ
Tuberk Toraks; 2015 Jun; 63(2):71-7. PubMed ID: 26167963
[TBL] [Abstract] [Full Text] [Related]
16. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract] [Full Text] [Related]
17. Curcumin inhibits lung cancer progression and metastasis through induction of foxo1.
Li ZC; Zhang LM; Wang HB; Ma JX; Sun JZ
Tumour Biol; 2014 Jan; 35(1):111-6. PubMed ID: 23888319
[TBL] [Abstract] [Full Text] [Related]
18. Biological prognostic factors in adult soft tissue sarcomas.
Ottaiano A; De Chiara A; Fazioli F; Talamanca AA; Mori S; Botti G; Milano A; Apice G
Anticancer Res; 2005; 25(6C):4519-26. PubMed ID: 16334136
[TBL] [Abstract] [Full Text] [Related]
